StockSelector.com
  Research, Select, & Monitor Wednesday, November 13, 2019 10:50:29 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Esperion Therapeutics, Inc.$40.16$.17.43%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Esperion Therapeutics, Inc. has an overall rank of 7003 out of 7018 stocks based on 3 positive rankings and 11 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $45.00 for Esperion Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Esperion Therapeutics is ranked 667.
Low Put/Call
Esperion Therapeutics has a low Put/Call ratio of 0.46 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Esperion Therapeutics is ranked 1066.
Debt-to-Equity
Esperion Therapeutics rank is 1686
Negative Rankings
Negative ROE
Esperion Therapeutics rank is 166
Negative ROA
Esperion Therapeutics rank is 203
Price-to-Book
Esperion Therapeutics rank is 292
Negative Net Margin
Esperion Therapeutics rank is 581
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Esperion Therapeutics is ranked 598.
Down EPS Surprise
Esperion Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Sales
Esperion Therapeutics rank is 701
Negative Cash Growth
Esperion Therapeutics rank is 786
High vPut/Call
Esperion Therapeutics has a high Put/Call ratio of 1.54 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Esperion Therapeutics is ranked 865.
10 Day Loss
Esperion Therapeutics rank is 1141
90 Day Loss
Esperion Therapeutics rank is 1250







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.